Researchers found that strong interactions between immune receptors promote antidrug antibody production, increasing the risk ...

Antibodies have transformed the way physicians treat patients with different pathologies. The next generation of monoclonal ...

Respiratory Impact: Data shows a significantly higher pulmonary burden, with a 33% increased risk of respiratory failure (aOR ...

The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer acetate (Copaxone, Glatopa), the agency announced on Wednesday. The warning ...

A new study by clinical researchers at Baylor College of Medicine and Texas Children’s Hospital offers insight on the primary triggers and management of childhood anaphylaxis. This severe, ...

New research based on real-world data largely aligns with the scientific literature, although one monoclonal antibody—dupilumab—stood out for its very low risk. Patients receiving monoclonal ...

Anaphylaxis is the most extreme form of severe allergic reactions which can be life threatening and requires emergency medical treatment. It can affect anyone of any age, sex, race and stature.

Good news for those who suffer from severe allergic reactions: a nasal spray containing epinephrine rather than a needle can now treat those frightening moments. The treatment, called Neffy, was ...

The TGA says people taking popular cold and flu supplements face the risk of life-threatening anaphylaxis from a herbal ...

Anaphylaxis can cause severe itching, difficulty breathing, fainting, and abdominal pain. These symptoms usually begin about 30 minutes after coming into contact with an allergy trigger. First, call ...